Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

475.555  -2.89 (-0.61%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRWD. CRWD was compared to 282 industry peers in the Software industry. While CRWD seems to be doing ok healthwise, there are quite some concerns on its profitability. CRWD is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
In the past year CRWD had a positive cash flow from operations.
CRWD had negative earnings in 4 of the past 5 years.
In the past 5 years CRWD always reported a positive cash flow from operatings.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

With a Return On Assets value of -1.98%, CRWD perfoms like the industry average, outperforming 58.87% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.99%, CRWD is in line with its industry, outperforming 57.45% of the companies in the same industry.
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a Gross Margin of 74.48%. This is in the better half of the industry: CRWD outperforms 64.89% of its industry peers.
In the last couple of years the Gross Margin of CRWD has remained more or less at the same level.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
CRWD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 14.17 indicates that CRWD is not in any danger for bankruptcy at the moment.
CRWD has a Altman-Z score of 14.17. This is amongst the best in the industry. CRWD outperforms 90.43% of its industry peers.
The Debt to FCF ratio of CRWD is 0.73, which is an excellent value as it means it would take CRWD, only 0.73 years of fcf income to pay off all of its debts.
CRWD has a Debt to FCF ratio of 0.73. This is in the better half of the industry: CRWD outperforms 75.53% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that CRWD is not too dependend on debt financing.
CRWD's Debt to Equity ratio of 0.22 is in line compared to the rest of the industry. CRWD outperforms 46.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Altman-Z 14.17
ROIC/WACCN/A
WACC10.76%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.85 indicates that CRWD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.85, CRWD perfoms like the industry average, outperforming 57.09% of the companies in the same industry.
CRWD has a Quick Ratio of 1.85. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Quick ratio of 1.85. This is comparable to the rest of the industry: CRWD outperforms 58.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.43%, which is quite good.
The Earnings Per Share has been growing by 79.46% on average over the past years. This is a very strong growth
Looking at the last year, CRWD shows a very strong growth in Revenue. The Revenue has grown by 25.94%.
Measured over the past years, CRWD shows a very strong growth in Revenue. The Revenue has been growing by 52.37% on average per year.
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%

3.2 Future

The Earnings Per Share is expected to grow by 17.66% on average over the next years. This is quite good.
The Revenue is expected to grow by 22.08% on average over the next years. This is a very strong growth
EPS Next Y-8.77%
EPS Next 2Y10.63%
EPS Next 3Y17.71%
EPS Next 5Y17.66%
Revenue Next Year21.71%
Revenue Next 2Y21.78%
Revenue Next 3Y22.23%
Revenue Next 5Y22.08%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 127.49 indicates a quite expensive valuation of CRWD.
CRWD's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CRWD to the average of the S&P500 Index (27.41), we can say CRWD is valued expensively.
With a Price/Forward Earnings ratio of 98.87, CRWD can be considered very expensive at the moment.
CRWD's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, CRWD is valued quite expensively.
Industry RankSector Rank
PE 127.49
Fwd PE 98.87
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRWD.
CRWD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 115.56
EV/EBITDA 4729.23
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CRWD's earnings are expected to grow with 17.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.63%
EPS Next 3Y17.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (7/14/2025, 3:00:07 PM)

475.555

-2.89 (-0.61%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners73.11%
Inst Owner Change0.08%
Ins Owners3.08%
Ins Owner Change2.62%
Market Cap118.53B
Analysts76.67
Price Target474.5 (-0.22%)
Short Float %3.6%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.96%
Min EPS beat(2)9.3%
Max EPS beat(2)18.62%
EPS beat(4)4
Avg EPS beat(4)11.48%
Min EPS beat(4)5.05%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)12.45%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)21.52%
Revenue beat(2)1
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.53%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.32%
Revenue beat(16)8
Avg Revenue beat(16)0.45%
PT rev (1m)12.03%
PT rev (3m)15.66%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)2.84%
EPS NY rev (1m)2.41%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 127.49
Fwd PE 98.87
P/S 28.66
P/FCF 115.56
P/OCF 85.73
P/B 34.35
P/tB 49.14
EV/EBITDA 4729.23
EPS(TTM)3.73
EY0.78%
EPS(NY)4.81
Fwd EY1.01%
FCF(TTM)4.12
FCFY0.87%
OCF(TTM)5.55
OCFY1.17%
SpS16.59
BVpS13.85
TBVpS9.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.48%
FCFM 24.8%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Debt/EBITDA 30.51
Cap/Depr 155.6%
Cap/Sales 8.63%
Interest Coverage N/A
Cash Conversion 5666.88%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 14.17
F-Score4
WACC10.76%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
EPS Next Y-8.77%
EPS Next 2Y10.63%
EPS Next 3Y17.71%
EPS Next 5Y17.66%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%
Revenue Next Year21.71%
Revenue Next 2Y21.78%
Revenue Next 3Y22.23%
Revenue Next 5Y22.08%
EBIT growth 1Y-861.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.18%
EBIT Next 3Y37.44%
EBIT Next 5Y36.81%
FCF growth 1Y37.6%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y34.63%
OCF growth 3Y33.96%
OCF growth 5Y69.1%